“glaxosmithkline” Archives

in
Entry Author Date Location
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M 10/07/19 Boston
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Akcea Shakes Up Management and Shows Three Executives the Door 09/23/19 Boston
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma 09/11/19 San Diego
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Colorectal Cancer Data Spurs Pfizer to Pay $11.4B for Array Bio 06/17/19 Boulder/Denver
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
The Biotech IPO Queue Grows Longer as Five More Companies File 05/28/19 National
Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera 05/15/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease 04/16/19 Boston
Page 2 of 24 « previous page · next page »